tyrosine has been researched along with ganciclovir in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Japón, MA; Low, MJ; Rubinstein, M | 1 |
Balzarini, J; De Clercq, E; Degrève, B; Esnouf, R | 1 |
Deng, WP; Gelovani, JG; Hwang, JJ; Lin, M; Liu, RS; Wang, HE; Wei, HJ; Yu, HM | 1 |
3 other study(ies) available for tyrosine and ganciclovir
Article | Year |
---|---|
Introduction of a point mutation into the mouse genome by homologous recombination in embryonic stem cells using a replacement type vector with a selectable marker.
Topics: Alleles; Amino Acid Sequence; Animals; Base Sequence; beta-Endorphin; Blotting, Southern; DNA; Embryo, Mammalian; Exons; Ganciclovir; Genetic Markers; Genetic Vectors; Genome; Gentamicins; Mice; Molecular Sequence Data; Mutagenesis, Insertional; Oligodeoxyribonucleotides; Point Mutation; Polymerase Chain Reaction; Pro-Opiomelanocortin; Protein Biosynthesis; Recombination, Genetic; Simplexvirus; Stem Cells; Thymidine Kinase; Tyrosine | 1993 |
Selective abolishment of pyrimidine nucleoside kinase activity of herpes simplex virus type 1 thymidine kinase by mutation of alanine-167 to tyrosine.
Topics: Alanine; Amino Acid Substitution; Antiviral Agents; Bone Neoplasms; Cell Division; Ganciclovir; Herpesvirus 1, Human; Humans; Osteosarcoma; Phosphorylation; Point Mutation; Purine Nucleosides; Pyrimidine Nucleosides; Thymidine Kinase; Transduction, Genetic; Tumor Cells, Cultured; Tyrosine | 2000 |
Molecular imaging with 123I-FIAU, 18F-FUdR, 18F-FET, and 18F-FDG for monitoring herpes simplex virus type 1 thymidine kinase and ganciclovir prodrug activation gene therapy of cancer.
Topics: Animals; Antiviral Agents; Arabinofuranosyluracil; Cell Line, Tumor; Female; Floxuridine; Fluorodeoxyglucose F18; Ganciclovir; Genetic Therapy; Herpesvirus 1, Human; Humans; Iodine Radioisotopes; Mice; Neoplasms; Prodrugs; Thymidine Kinase; Tyrosine | 2006 |